Literature DB >> 4469689

Lesch-Nyhan syndrome: evidence for abnormal adrenergic function.

S Rockson, R Stone, M Van der Weyden, W N Kelley.   

Abstract

Subjects with the Lesch-Nyhan syndrome (hypoxanthine-guanine phosphoribosyltransferase deficiency with self-mutilation) exhibit an apparently unique pattern of adrenergic dysfunction characterized by elevated plasma dopamine beta-hydroxylase activity and an absence of pressor response to acute sympathetic stimulation. Patients with a partial deficiency of hypoxanthine-guanine phosphoribosyltransferase without self-mutilation do not exhibit these abnormalities of adrenergic function.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4469689     DOI: 10.1126/science.186.4167.934

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  5 in total

1.  The use of 5-hydroxytryptophan in a child with Lesch-Nyhan syndrome.

Authors:  R D Ciaranello; T F Anders; J D Barchas; P A Berger; H M Cann
Journal:  Child Psychiatry Hum Dev       Date:  1976

2.  Adrenergic regulation of blood pressure in chronic renal failure.

Authors:  J J Lilley; J Golden; R A Stone
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

3.  Double-blind clinical trial of 5-hydroxytryptophan in a case of Lesch-Nyhan syndrome.

Authors:  C D Frith; E C Johnston; M H Joseph; R J Powell; R W Watts
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-07       Impact factor: 10.154

Review 4.  Hypoxanthine-guanine phosphoribosyl transferase deficiency.

Authors:  C H de Bruyn
Journal:  Hum Genet       Date:  1976-02-29       Impact factor: 4.132

Review 5.  A review of the molecular basis of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency.

Authors:  D G Sculley; P A Dawson; B T Emmerson; R B Gordon
Journal:  Hum Genet       Date:  1992-11       Impact factor: 4.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.